0001209191-21-008899.txt : 20210209
0001209191-21-008899.hdr.sgml : 20210209
20210209172249
ACCESSION NUMBER: 0001209191-21-008899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jorgensen Nathan D.
CENTRAL INDEX KEY: 0001842523
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39979
FILM NUMBER: 21607939
MAIL ADDRESS:
STREET 1: C/O VOR BIOPHARMA INC.
STREET 2: 100 CAMBRIDGEPARK DRIVE, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vor Biopharma Inc.
CENTRAL INDEX KEY: 0001817229
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 430
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-655-6580
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 430
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-09
0
0001817229
Vor Biopharma Inc.
VOR
0001842523
Jorgensen Nathan D.
C/O VOR BIOPHARMA INC.
100 CAMBRIDGEPARK DRIVE, SUITE 400
CAMBRIDGE
MA
02140
0
1
0
0
Chief Financial Officer
Common Stock
2021-02-09
4
C
0
3534
A
29269
D
Series B Preferred Stock
2021-02-09
4
C
0
48076
0.00
D
Common Stock
3534
0
D
Each share of Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 13.6 for-one basis, and had no expiration date.
/s/ Jason Minio, Attorney-in-Fact
2021-02-09